# Sartorius financial performance and reorganization

> Developing situation record from CLSTR: https://clstr.news/situations/sartorius-financial-performance-and-reorganization
> Updated: 2026-10-26T06:28:37.000Z. Sources: 7. Developments: 2.

Sartorius AG reported a 51 percent increase in net profit for the first nine months of fiscal 2026, reaching 188.3 million euros. This growth was attributed to sales increases and positive volume development. Alongside these results, the company announced a strategic reorganization named ‘One Sartorius’, set to take effect on January 1, 2027. This plan involves consolidating management responsibilities and transitioning to two new business segments: Bioprocessing Solutions and Research Solutions.

Following these financial disclosures, Jefferies raised its price target for Sartorius from 307 to 315 euros while maintaining a ‘Buy’ rating. Analysts noted a recovery in the Bioprocess Solutions division and expected strength in the Lab Products & Services segment to drive annual targets upward. The focus remains on the sustainable stabilization of product and service revenues, particularly within critical life-science workflows.

## Timeline

### 2026-10-26: Sartorius receives price target hike from Jefferies

Jefferies raised its price target for Sartorius to 315 euros, maintaining a ‘Buy’ rating following a recovery in its Bioprocess Solutions division.

4 sources. https://clstr.news/cluster/jefferies-raises-sartorius-price-target-to-315-euros

### 2026-10-22: Sartorius reports profit growth and announces structural reorganization

Sartorius reports a 51% increase in nine-month net profit for 2026 and announces a strategic reorganization for 2027.

6 sources. https://clstr.news/cluster/sartorius-and-vossloh-report-nine-month-financial-results

---
Cite as: Sartorius financial performance and reorganization. CLSTR, https://clstr.news/situations/sartorius-financial-performance-and-reorganization